Back to News
Market Impact: 0.25

2 Top ETFs I Can't Wait to Buy More of in My Retirement Account This November

SCHDJEPQABBV
Company FundamentalsCapital Returns (Dividends / Buybacks)Futures & OptionsTechnology & InnovationInterest Rates & YieldsDerivatives & Volatility
2 Top ETFs I Can't Wait to Buy More of in My Retirement Account This November

The article highlights the Schwab U.S. Dividend Equity ETF (SCHD) and the JPMorgan Nasdaq Equity Premium Income ETF (JEPQ) as strategic, complementary investments for long-term portfolios, emphasizing their blend of income and growth with managed volatility. SCHD, which tracks the Dow Jones U.S. Dividend 100 Index, offers a 3.8% dividend yield and has achieved an 11.6% average annual return since 2011 with a 0.06% expense ratio. JEPQ employs an options overlay on Nasdaq-100 stocks to generate monthly income, delivering over an 11% income yield and 16.2% average annual returns since 2022 at a 0.35% expense ratio, appealing to investors seeking high income and tech exposure with risk mitigation.

Analysis

The Schwab U.S. Dividend Equity ETF (SCHD) is presented as a robust core holding for retirement accounts, tracking the Dow Jones U.S. Dividend 100 Index with a low 0.06% expense ratio. It focuses on financially healthy companies with sustainable and rising dividends, currently yielding approximately 3.8%, which is more than triple the S&P 500's 1.2%. The fund has demonstrated strong long-term performance, delivering an 11.6% average annual total return since its 2011 inception. The JPMorgan Nasdaq Equity Premium Income ETF (JEPQ) offers a dual mandate of monthly income and less volatile exposure to the Nasdaq-100, with a 0.35% expense ratio. Its strategy combines a high-growth tech equity portfolio with a disciplined out-of-the-money call option overlay. This options writing strategy has generated an income yield exceeding 11% over the past 12 months, contributing to a 16.2% average annual total return since its 2022 inception. These ETFs are positioned as complementary investments, with SCHD providing dividend growth and JEPQ offering high monthly income and tech exposure. Both funds aim to combine income and growth with lower risk profiles, aligning with a strategy focused on attractive returns and reduced volatility. The overall sentiment surrounding these funds is extremely positive, with an optimistic tone regarding their suitability for long-term investment. The inclusion of AbbVie (ABBV) as a top holding in SCHD, with its consistent dividend increases and strong R&D investment, exemplifies the quality of companies targeted by SCHD's strategy. JEPQ's use of applied data science and fundamental research for its equity portfolio, combined with its options overlay, underscores a sophisticated approach to generating yield and managing risk in the tech sector.